Bengaluru: Biocon Limited announced that it has retained its position amongst the Top 10 Employers in the global biotech, pharma and biopharma sector, at number eight in 2023. The recognition is bestowed by the US-based Science magazine.
Employees across Biocon and Biocon Biologics participated in the annual Top 20 Employers Survey, which Science magazine has been conducting for over a decade to identify and celebrate the finest pharma and biotech companies.
Kiran Mazumdar Shaw, Chairperson, Biocon & Biocon Biologics, said, “We are delighted to be recognised once again amongst the Top 10 global biotech employers. We are extremely proud of the quality of talent we have nurtured at the Biocon Group. Our people are driven by the shared purpose of enabling ‘health equity’ and are committed to develop world-class biopharmaceutical products. This recognition reflects our dedication towards enabling ‘people equity’ by creating an empowering and inclusive workplace where everyone gets an opportunity to advance their careers and be recognised and rewarded for their exemplary contributions.”
“This consistent recognition will motivate us to keep pushing the boundaries to create a highly thriving workplace culture that promotes unconventional thinking, focus on innovation, mutual respect, and collaboration. By empowering our people, we inculcate in them a strong spirit to stay the course even in the face of insurmountable challenges” she added.
In an interview with the Science magazine, Sandeep Athalye, Chief Development Officer, Biocon Biologics, said, “Our people are motivated to be innovative and approach the global problem of healthcare access with a lens of making medicines affordable and reachable to more people, while at the same time finding ways to make these therapies better for patients to use.”
As has been done for several years, a white sheet describing the survey and project timeline was sent to both public relations and human resources contacts in the biotech and pharma industry in the American Association for the Advancement of Science (AAAS) database several weeks before launching the online survey. This year’s web-based survey was conducted from March 1–31, 2023.
A mixed methodology was used again to recruit participants for this year’s survey. The first part of this methodology included emailed invitations to roughly 42,000 individuals who were located worldwide; these individuals were AAAS members, Science website registrants, and Science Careers registrants. The second part of the methodology included several email blasts to approximately 225 human resource (HR) contacts at industry firms and biotech/pharma advertising agencies from the Science Careers sales database.
This year, the global survey was completed by over 6,800 respondents, who came from North America (59 per cent), Europe (18 per cent), Asia/Pacific Rim (16 per cent), Rest of the World (7 per cent). Also, 36 per cent worked in biotechnology, 40 per cent in biopharma, 20 per cent in pharma and 8 per cent in others. The respondents included 28 per cent doctorates, 34 per cent with a Master’s degree, 32 per cent with a Bachelor’s degree and 6 per cent others. In terms of gender, 52 per cent of the respondents were male, 42 per cent were female and 6 per cent preferred not to respond.